Reports have shown that the loss of DNMT3A or its mutant can cause an abnormal proliferation of hematopoietic stem cells, which then transform into preleukemic stem cells that are resistant to chemo-drugs and responsible for relapse in AML patients [47]. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.